Generics in Singapore
Generics in Singapore
SUMMARY
Generics in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Singaporean generics market had total revenues of $0.4bn in 2019, representing a compound annual growth rate (CAGR) of 5.9% between 2015 and 2019.
- Market consumption volume increased with a CAGR of 0.2% between 2015 and 2019, to reach a total of 89.9% in 2019.
- Growth in the Singaporean pharmaceuticals market has helped the city-state become a regional hub for the manufacturing, research, and development for multinational pharmaceutical companies.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Singapore
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore generics market with five year forecasts by both value and volume
- What was the size of the Singapore generics market by value in 2019?
- What will be the size of the Singapore generics market in 2024?
- What factors are affecting the strength of competition in the Singapore generics market?
- How has the market performed over the last five years?
- How large is Singapore’s generics market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Teva Pharmaceutical Industries Limited
8.2. Pfizer Inc.
8.3. Abbott Laboratories
8.4. Mylan N.V.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Teva Pharmaceutical Industries Limited
8.2. Pfizer Inc.
8.3. Abbott Laboratories
8.4. Mylan N.V.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Singapore generics market value: $ million, 2015-19
Table 2: Singapore generics market volume: % of total pharma, 2015-19
Table 3: Singapore generics market geography segmentation: $ million, 2019
Table 4: Singapore generics market value forecast: $ million, 2019-24
Table 5: Singapore generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Abbott Laboratories: key facts
Table 14: Abbott Laboratories: Annual Financial Ratios
Table 15: Abbott Laboratories: Key Employees
Table 16: Abbott Laboratories: Key Employees Continued
Table 17: Mylan N.V.: key facts
Table 18: Mylan N.V.: Annual Financial Ratios
Table 19: Mylan N.V.: Key Employees
Table 20: Singapore size of population (million), 2015-19
Table 21: Singapore gdp (constant 2005 prices, $ billion), 2015-19
Table 22: Singapore gdp (current prices, $ billion), 2015-19
Table 23: Singapore inflation, 2015-19
Table 24: Singapore consumer price index (absolute), 2015-19
Table 25: Singapore exchange rate, 2015-19
Table 1: Singapore generics market value: $ million, 2015-19
Table 2: Singapore generics market volume: % of total pharma, 2015-19
Table 3: Singapore generics market geography segmentation: $ million, 2019
Table 4: Singapore generics market value forecast: $ million, 2019-24
Table 5: Singapore generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Abbott Laboratories: key facts
Table 14: Abbott Laboratories: Annual Financial Ratios
Table 15: Abbott Laboratories: Key Employees
Table 16: Abbott Laboratories: Key Employees Continued
Table 17: Mylan N.V.: key facts
Table 18: Mylan N.V.: Annual Financial Ratios
Table 19: Mylan N.V.: Key Employees
Table 20: Singapore size of population (million), 2015-19
Table 21: Singapore gdp (constant 2005 prices, $ billion), 2015-19
Table 22: Singapore gdp (current prices, $ billion), 2015-19
Table 23: Singapore inflation, 2015-19
Table 24: Singapore consumer price index (absolute), 2015-19
Table 25: Singapore exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Singapore generics market value: $ million, 2015-19
Figure 2: Singapore generics market volume: % of total pharma, 2015-19
Figure 3: Singapore generics market geography segmentation: % share, by value, 2019
Figure 4: Singapore generics market value forecast: $ million, 2019-24
Figure 5: Singapore generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in Singapore, 2019
Figure 7: Drivers of buyer power in the generics market in Singapore, 2019
Figure 8: Drivers of supplier power in the generics market in Singapore, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Singapore, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in Singapore, 2019
Figure 11: Drivers of degree of rivalry in the generics market in Singapore, 2019
Figure 1: Singapore generics market value: $ million, 2015-19
Figure 2: Singapore generics market volume: % of total pharma, 2015-19
Figure 3: Singapore generics market geography segmentation: % share, by value, 2019
Figure 4: Singapore generics market value forecast: $ million, 2019-24
Figure 5: Singapore generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in Singapore, 2019
Figure 7: Drivers of buyer power in the generics market in Singapore, 2019
Figure 8: Drivers of supplier power in the generics market in Singapore, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Singapore, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in Singapore, 2019
Figure 11: Drivers of degree of rivalry in the generics market in Singapore, 2019
